CN201438187U - Diabetes detection and analysis device - Google Patents
Diabetes detection and analysis device Download PDFInfo
- Publication number
- CN201438187U CN201438187U CN2009201104483U CN200920110448U CN201438187U CN 201438187 U CN201438187 U CN 201438187U CN 2009201104483 U CN2009201104483 U CN 2009201104483U CN 200920110448 U CN200920110448 U CN 200920110448U CN 201438187 U CN201438187 U CN 201438187U
- Authority
- CN
- China
- Prior art keywords
- result
- blood sugar
- unit
- diagnostic
- diagnostic result
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The utility model provides a diabetes detection and analysis device which comprises a detection unit, an input unit, a storage unit, an analysis unit and a display unit, wherein the detection unit is used for detecting blood-glucose or ketone body and acquiring the detection results; the input unit is used for the user to input the detection results; the storage unit is connected with the detection unit and used for classification storage of the detection results acquired by the detection unit and prestorage of related diagnosis results reference information of various diabetes and corresponding recommended e-books of various diagnosis results; the analysis unit is connected with the storage unit and the input unit and used for acquiring the diagnosis results and the corresponding recommended e-books of the diagnosis results according to the corresponding diagnosis results reference information of the detection results after storing the detection results or receiving the detection results input by the user; and the display unit is connected with the analysis unit and used for displaying the diagnosis results and the recommended e-books acquired by the analysis unit. The detection device can perform analysis calculation for the related detection results of the diabetes and can inform the patients of the current condition and the measures against the abnormal condition.
Description
Technical field
The present invention relates to medical instruments field, particularly a kind of diabetes check and analysis device.
Background technology
Diabetes are chronic diseases of a kind of sugar, fat, protein metabolism disorder, thereby mainly show as in the blood of human body high many drinks, many foods, diuresis, the symptom such as weak of causing of sugar content, diabetes also can't thoroughly be cured at present, just need carry out state of illness monitoring and treatment control for a long time in case get diabetes, to cause pathologies such as human recycle system, nervous system if diabetes treatment control is bad, and then cause hypertension, heart disease, ephrosis, headstroke, blind, complication such as biped festers, have a strong impact on diabetic's work and life.
Diabetic's treatment at present mainly is controlled to be the master with family's oneself's state of illness monitoring and treatment.Patient oneself state of illness monitoring mainly uses blood glucose meter, sphygmomanometer, ketoboidies instrument, fast detecting products such as microdose urine protein testing card carry out the state of an illness to every pointer and detect, when the result occurs needing in time to go hospital to seek medical advice after unusual or oneself searches reason and adjust therapeutic scheme and treat and control the state of an illness, harm is healthy in order to avoid sb.'s illness took a turn for the worse.
The fast detecting product provides very big convenience for diabetic's laboratory indexes; now increasing patient is in and oneself just can chemically examines detection by the own fast detecting product of buying; saved the trouble that frequent race hospital chemically examines; but because the patient is not very professional medical personnel; when using these fast detecting products; query occurring through regular meeting, is not very to understand to the meaning of testing result representative.Such as: need the often fast detecting product blood glucose meter of use as the diabetic, ketoboidies instrument and microdose urine protein testing are stuck in house and carry out oneself's detection, after finishing, detection shows testing result, most patient sees behind the result and does not know the meaning of some results representative, normally or undesired? does what meaning the result raise and represents? descended and represented what meaning? should take which type of counter-measure for abnormal conditions? a lot of diabetics very do not understand these, some situation need be consulted a lot of expert data or consulting profession doctor, but this understands the state of an illness fast and in time takes counter-measure to bring inconvenience for the patient, and if some emergency condition incur loss through delay to handle and cause danger possibly.Such as: when detecting blood sugar and be lower than 2.9mmol/L, and during with the hypoglycemia symptom, just must take immediately, otherwise just very likely patient body be brought serious harm or life danger at hypoglycemic emergency measure as the diabetic.
Summary of the invention
The utility model provides a kind of diabetes check and analysis device, and described device comprises: detecting unit is used to carry out blood sugar and/or ketoboidies and detects, and obtains testing result; Input block is used for importing testing result for the user; Storage unit, be connected in described detecting unit, be used for testing result classification and storage that described detecting unit is obtained, and the multiple diabetes dependent diagnostic reference information as a result that prestores, and the recommendation e-book of various diagnostic result correspondences, wherein every kind of described diagnostic result reference information comprises the diagnostic result of testing result and these testing result correspondences of different spans; Analytic unit, be connected in described storage unit and input block, be used for after the testing result of described testing result of storage or reception user input, obtaining the recommendation e-book of diagnostic result and described diagnostic result correspondence according to the diagnostic result reference information of described testing result correspondence; Display unit is connected in described analytic unit, is used to show the diagnostic result that described analytic unit obtains and recommends e-book.
The pick-up unit that the utility model provides adds the diagnoses and treatment inference system of specialty on the basis of existing fast detecting product, can carry out the analytical calculation and the state of an illness that the patient is current and the counter-measure of abnormal conditions to diabetes coherent detection result and inform the patient, the greatly current state of an illness of the understanding oneself of the fast simple science of the help patient of degree and promptly counter-measure, the harm that the deduction and exemption emergency condition is brought.
Description of drawings
In order to be illustrated more clearly in the embodiment of the invention or technical scheme of the prior art, to do to introduce simply to the accompanying drawing of required use in embodiment or the description of the Prior Art below, apparently, accompanying drawing in describing below only is some embodiments of the present invention, for those of ordinary skills, under the prerequisite of not paying creative work, can also obtain other accompanying drawing according to these accompanying drawings.
Fig. 1 is the Organization Chart of the diabetes check and analysis device among the utility model embodiment;
Fig. 2 is the Organization Chart of the diabetes check and analysis device detecting unit among the utility model embodiment;
Fig. 3 is the Organization Chart of the diabetes check and analysis device storage unit among the utility model embodiment;
Fig. 4 is the Organization Chart of the diabetes check and analysis device analysis unit among the utility model embodiment;
Fig. 5 is the Organization Chart of the diabetes check and analysis device among the utility model embodiment;
Fig. 6 is the Organization Chart of the Data Management Unit of the diabetes check and analysis device among the utility model embodiment;
Fig. 7 is the Organization Chart of the diabetes check and analysis device among the utility model embodiment.
Embodiment
Below in conjunction with the accompanying drawing in the embodiment of the invention, the technical scheme in the embodiment of the invention is clearly and completely described, obviously, described embodiment only is the present invention's part embodiment, rather than whole embodiment.Based on the embodiment among the present invention, those of ordinary skills belong to the scope of protection of the invention not making the every other embodiment that is obtained under the creative work prerequisite.
As shown in Figure 1, the utility model provides a kind of diabetes check and analysis device, described device comprises detecting unit 101, storage unit 102, analytic unit 103, display unit 104 and input block 105: detecting unit 101, be connected in described storage unit 102, be used to carry out blood sugar and/or ketoboidies and detect, and obtain testing result; Input block 105 is connected in described analytic unit 103, is used for importing testing result for the user; Storage unit 102, be connected in described detecting unit 101, be used for testing result classification and storage that described detecting unit 101 is obtained, and the multiple diabetes dependent diagnostic reference information as a result that prestores, and the recommendation e-book of various diagnostic result correspondences, wherein every kind of described diagnostic result reference information comprises the diagnostic result of testing result and these testing result correspondences of different spans; Analytic unit 103, be connected in described storage unit 102 and input block 105, be used for after the testing result of described testing result of storage or reception user input, obtaining the recommendation e-book of diagnostic result and described diagnostic result correspondence according to the diagnostic result reference information of described testing result correspondence; Display unit 104 is connected in described analytic unit 103, is used to show the diagnostic result that described analytic unit 103 obtains and recommends e-book.
As shown in Figure 2, detecting unit 101 can further comprise among the another embodiment of the utility model: blood sugar test module 1011 and ketoboidies detection module 1012.Usually the diabetic all should carry out the blood ketone body monitoring when stress, take place other accompanying diseases or blood sugar above 16.7mmol/L (300mg/dl).
The principle of work of blood sugar test module 1011 is the glucose and glucose oxidase (GOD) that is fixed on blood sugar strip surface or glucose dehydrogenase (GDH) reaction that utilizes in the blood, and electron transfer or H are followed in this reaction
+Shift, by electron mediator or H
+Substrate is delivered to the strip surface with reaction signal.Blood sugar test module 1011 applies a constant operating voltage to strip, makes the electron mediator or the H that participate in after the enzyme reaction
+The substrate oxidation produces oxidation current, and the size of oxidation current is directly proportional with concentration of glucose.The size of blood sugar test module 1011 record oxidation currents, and converse blood sugar concentration numerical value (blood sugar test result) it is kept at storage unit 102.
Ketoboidies in the blood comprises D-3-hydroxybutyric acid (beta-hydroxybutyric acid), acetoacetate and acetone, and the three respectively accounts for 78%, 20% and 2% in the normal blood.The D-3-hydroxybutyric acid that detects in the blood can in time reflect the ketoacidosis degree.The principle of work of ketoboidies detection module 1012 is to utilize the D-3-hydroxybutyric acid in the blood to react with coenzyme NAD under the catalytic action of the D-3-hydroxybutyric dehydrogenase (HBD) that is fixed on the strip surface, the oxidized generation acetoacetate of D-3-hydroxybutyric acid, NAD is reduced to NADH simultaneously; Ketoboidies detection module 1012 applies a constant operating voltage, makes NADH be oxidized to NAD to strip, produces oxidation current, and the size of oxidation current is directly proportional with D-3-hydroxybutyric acid concentration.The size of ketoboidies detection module 1012 record oxidation currents, and the concentration numerical value (ketoboidies testing result) that converses ketoboidies is kept at storage unit 102 with it.
As shown in Figure 3, described storage unit 102 further comprises: blood sugar effects memory module 1021 is used for blood sugar test result queue time of will obtain and by different time period classification and storage; Ketoboidies is memory module 1022 as a result, is used for the ketoboidies testing result mark time and the storage of will obtain; Diagnostic data memory module 1023, multiple diabetes dependent diagnostic reference information as a result is used to prestore, and the recommendation e-book of various diagnostic result correspondences, wherein every kind of described diagnostic result reference information comprises the diagnostic result of testing result and these testing result correspondences of different spans.Wherein multiple diabetes dependent diagnostic reference information as a result can comprise following diagnostic result reference information: blood sugar diagnostic result reference information, ketoboidies diagnostic result reference information, blood pressure diagnostic result reference information, kidney Gernral Check-up be reference information, glycosylated hemoglobin diagnostic result reference information, physical fitness diagnosis reference information, triglyceride diagnostic result reference information, serum creatinine diagnostic result reference information as a result as a result.It should be noted that; more than cited diagnostic result reference information be not to be used for limiting the utility model; add other diagnostic result reference informations according to actual needs or use the combination of any kind of above-mentioned reference information, all should be included in the protection domain of the present utility model.
After blood sugar test module 1011 obtained the blood sugar test result, the described blood sugar test result that the blood sugar effects memory module 1021 of storage unit 102 will be obtained at every turn was by different time period classification and storage.Classification is to classify automatically according to the time that the user measures, but as the automatic classification user's manual modification that do not conform to the actual conditions.Automatically classification is judged automatically by following time range:
1, Measuring Time is categorized as automatically at (6:00-8:00): morning is blood sugar before the meal;
2, Measuring Time is categorized as automatically at (8:00-10:00): morning is blood sugar after the meal;
3, Measuring Time is categorized as automatically at (10:00-13:00): ante prandium blood sugar;
4, Measuring Time is categorized as automatically at (13:00-15:00): blood sugar after the lunch;
5, Measuring Time is categorized as automatically at (17:00-19:00): blood sugar before the dinner;
6, Measuring Time is categorized as automatically at (19:00-21:00): blood sugar after the dinner;
7, Measuring Time is categorized as automatically at (21:00-23:00): the preceding blood sugar of sleeping;
8, Measuring Time is categorized as automatically at (2:00-3:00): morning 2-3 point blood sugar;
9, be categorized as automatically At All Other Times: random blood sugar.
After the blood sugar test result classification, by the blood sugar classification with preserve automatically detection time.
In the above-mentioned classification all before the meal blood sugar and morning 2-3 point blood sugar and random blood sugar carry out illness analysis by fasting blood-glucose, all postprandial blood sugars are pressed the postprandial blood sugar analysis.
Also there is blood sugar diagnostic result reference information (be the blood sugar test range of results and the corresponding diagnostic result thereof of different time sections, above-mentioned reference information is provided with according to " Chinese diabetes control guide ") in the diagnostic data memory module 1023 of storage unit 102:
Fasting blood-glucose:
1, range of blood sugar: 4.4-6.1 (mmol/L) diagnostic result: blood sugar is normal, is controlled at perfect condition;
2, range of blood sugar: 6.2-7.0 (mmol/L) diagnostic result: glycemic control is good;
3, range of blood sugar: greater than 7.0 or HI (mmol/L) diagnostic result: glycemic control is poor, asks referring physician;
4, range of blood sugar: 3.9-4.3 (mmol/L) diagnostic result: glycemic control is good;
5, range of blood sugar: 2.9-3.8 (mmol/L) diagnostic result: hypoglycemia may;
6, range of blood sugar: be lower than 2.9 or LO (mmol/L) diagnostic result: hypoglycemia, ask referring physician.
Postprandial blood sugar:
1, range of blood sugar: 4.4-8.0 (mmol/L) diagnostic result: blood sugar is normal, is controlled at perfect condition;
2, range of blood sugar: 8.1-10.0 (mmol/L) diagnostic result: glycemic control is good;
3, range of blood sugar: greater than 10.0 or HI (mmol/L) diagnostic result: glycemic control is poor, asks referring physician;
4, range of blood sugar: 3.9-4.3 (mmol/L) diagnostic result: glycemic control is good;
5, range of blood sugar: 2.9-3.8 (mmol/L) diagnostic result: hypoglycemia may;
6, range of blood sugar: be lower than 2.9 or LO (mmol/L) diagnostic result: hypoglycemia, ask referring physician.
The diagnostic data memory module 1023 of storage unit 102 also has the e-book (corresponding relation that comprises e-book and diagnostic result) of different blood sugar diagnostic result correspondences, as: diagnostic result is that " glycemic control is poor, asks referring physician " corresponding recommendation e-book catalogue is: " diabetes controlled target ", " target of dietary therapy and principle ", " principle of exercise therapy ", " oral antidiabetic drug treatment ", " insulinize "
The described ketoboidies testing result that memory module 1022 storages as a result of the ketoboidies of storage unit 102 are obtained at every turn, the ketoboidies diagnostic result reference information that also prestores in the diagnostic data memory module 1023 of storage unit 102 comprises the diagnostic result of various concentration range correspondences and the recommendation e-book of described diagnostic result correspondence.
The ketoboidies testing result that prestores scope is formulated according to " Chinese diabetes control guide ", as:
Ketoboidies result: less than 0.6 diagnostic result: the ketoboidies level is normal;
Ketoboidies result: 0.6-1.5 diagnostic result: ketosis (suspicious);
Ketoboidies result: greater than 1.5 diagnostic results: ketoacidosis.
The diagnostic data memory module 1023 of storage unit 102 also has the e-book of different ketoboidies diagnostic result correspondences.
Blood pressure diagnostic result reference information, kidney health detection card diagnostic result reference information, glycosylated hemoglobin diagnostic result reference information, physical fitness diagnosis reference information, triglyceride diagnostic result reference information and serum creatinine diagnostic result reference information as a result and the recommendation e-book of the diagnostic result correspondence in the above-mentioned reference information also can prestore in the diagnostic data memory module 1023:
One, blood pressure diagnostic result reference information is for example:
1, the systolic pressure [SBP]＜120 and pressure [DBP]＜80 diagnostic result that contracts: ideal bp;
2, the systolic pressure [SBP]=120～129 and/or pressure [DBP]=80～84 diagnostic result that contracts: normal arterial pressure;
3, the systolic pressure [SBP]=130～139 and/or pressure [DBP]=85～89 diagnostic result that contracts: normal high value;
4, the systolic pressure [SBP]=140～159 and/or pressure [DBP]=90～99 diagnostic result that contracts: 1 grade of hypertension;
5, the systolic pressure [SBP]=160～179 and/or pressure [DBP]=100～109 diagnostic result that contracts: 2 grades of hypertension;
6, the systolic pressure [SBP] 〉=100 and/or pressure [DBP] 〉=110 diagnostic result that contracts: 3 grades of hypertension;
7, the systolic pressure [SBP] 〉=140 and pressure [DBP]＜90 diagnostic result that contracts: ISH.
Two, kidney health detection card diagnostic result reference information is for example:
1, colour band, diagnostic result: the albumin content that detects in the urine sample is greater than 100mg/L, microalbuminuria or occurred a large amount of albuminurias should in time be removed hospital therapy, and the periodic monitoring microdose urine protein;
2, two colour bands, diagnostic result: detect that albuminous content is 50-100mg/L in the urine, microalbuminuria early stage, kidney injury pathology early stage.If first discovery should go to hospital further to check;
3, three colour bands, diagnostic result: detect that albuminous content is 20-50mg/L in the urine, microalbuminuria early stage, kidney injury pathology early stage is if first discovery should go to hospital further to check;
4, four colour bands, diagnostic result: detect albumin in the urine and be negative promptly, belong to normal range less than 20mg/L;
5, no colour band, diagnostic result: strip lost efficacy.
Three, glycosylated hemoglobin diagnostic result reference information is for example:
1, less than 4% diagnostic result: glycosylated hemoglobin is on the low side
2,4-6% diagnostic result: glycosylated hemoglobin is normal
3, greater than 6% diagnostic result: glycosylated hemoglobin is higher
Four, reference information is for example as a result for physical fitness diagnosis:
1, less than 18.5 diagnostic results: low birth weight, onset risk is low, but then increases when other clinical setting is arranged;
2,18.5～23.9 diagnostic results: body weight is normal, and onset risk is general;
3,24.0～27.9 diagnostic results: overweight, onset risk increases;
4, greater than 28.0 diagnostic results: body weight obesity, onset risk height.
Five, triglyceride diagnostic result reference information is for example:
1,0.56-1.7mmol/L diagnostic result: normal triglyceride levels;
2,2.83-5.65mmol/L diagnostic result: criticality hypertriglyceridemia;
3, greater than the 5.65mmol/L diagnostic result: clear and definite hypertriglyceridemia.
Six, serum creatinine diagnostic result reference information is for example:
1, less than 88.4 μ moI/L diagnostic results: serum creatinine (Cr) lowers;
2,88.4-176.8 μ moI/L diagnostic result: serum creatinine (Cr) is normal;
3, greater than 176.8 μ moI/L diagnostic results: serum creatinine (Cr) increases.
As shown in Figure 4, in further embodiment of this invention, analytic unit 103 further comprises:
Analysis of blood sugar module 1031 is used for according to the time of described blood sugar test result and mark, retrieving the recommendation e-book of diagnostic result and described diagnostic result correspondence in blood sugar diagnostic result reference information behind the described blood sugar test result of storage;
The user imports analysis module 1033, after the detection data of reception user input, according to the diagnostic result reference information of correspondence, obtains the recommendation e-book of diagnostic result and described diagnostic result correspondence.
Various diagnostic result reference informations in the diagnostic data memory module 1023 of storage unit 102 are as the analytical standard of analytic unit 103.For example to obtain blood sugar test result's time be 20:00 to the blood sugar test module 1011 of one-time detection unit 101, blood glucose concentration value is 11 (mmol/L), and the blood sugar effects memory module 1021 of storage unit 102 is preserved described blood sugar test result by blood sugar classification after the dinner.The analysis of blood sugar module 1031 of analytic unit 103 is judged this blood sugar test result according to the reference information of the blood sugar that prestores and is belonged to the 3rd of postprandial blood sugar scope, corresponding diagnostic result is " glycemic control is poor; ask referring physician ", after obtaining diagnostic result, obtain the recommendation e-book corresponding, control display unit 104 display analysis results and above-mentioned recommendation e-book catalogue with this diagnostic result.The user can select the e-book of desire reading by input block 105, and the e-book page turning that will show.
The ketoboidies analysis module 1032 of analytic unit 103 is judged the diagnostic result that obtains the described ketoboidies testing result correspondence that prestores and the recommendation e-book of described diagnostic result correspondence according to the reference information of the ketoboidies that prestores after the described ketoboidies testing result of the ketoboidies of storage unit 102 memory module 1022 storages as a result.The user can select the e-book catalogue that will read by input block 105, and described analytic unit 103 can be opened e-book, and control display unit 104 shows that related contents read reference for users.
After the user of analytic unit 103 imports the testing result of analysis module 1033 reception users by input block 105 inputs, obtain the recommendation e-book of diagnostic result and described diagnostic result correspondence according to the diagnostic result reference information of described testing result correspondence.Analytic unit 103 can be opened e-book, and control display unit 104 shows that related content supplies the user to read reference.The testing result of user's input can comprise: blood pressure testing result, kidney health detection result, glycosylated hemoglobin testing result, physical examinations result, triglyceride testing result or serum creatinine testing result.The user imports analysis module 1033 and can be the interface that the user provides which kind of testing result of selection input, show by display unit 104, the user can select the kind of the testing result imported by input block 105, and the kind according to the testing result of user's input when the user imports analysis module 1033 and obtains the recommendation e-book of diagnostic result and described diagnostic result correspondence is obtained.
The user imports analysis module 1033 can show the option that has blood pressure range in display unit 104 during input blood pressure testing result, for user's selection, option for example:
1, the systolic pressure [SBP]＜120 and pressure [DBP]＜80 of contracting;
2, the systolic pressure [SBP]=120～129 and/or pressure [DBP]=80～84 of contracting;
3, the systolic pressure [SBP]=130～139 and/or pressure [DBP]=85～89 of contracting;
4, the systolic pressure [SBP]=140～159 and/or pressure [DBP]=90～99 of contracting;
5, the systolic pressure [SBP]=160～179 and/or pressure [DBP]=100～109 of contracting;
6, the systolic pressure [SBP] 〉=100 and/or pressure [DBP] 〉=110 of contracting;
7, the systolic pressure [SBP] 〉=140 and pressure [DBP]＜90 of contracting.
Input kidney health detection as a result the time user import analysis module 1033 and can in display unit 104, show the option that has kidney health detection card colour band quantity, for user's selection, option for example:
1, colour band;
2, two colour bands;
3, three colour bands;
4, four colour bands;
5, no colour band.
The user imports analysis module 1033 can show the option that has the glycosylated hemoglobin scope in display unit 104 during input glycosylated hemoglobin testing result, for user's selection, option for example:
1, less than 4%;
2、4-6％；
3, greater than 6%.
Defeated physique (Body Mass Index, BMI) user imports analysis module 1033 can show the option that has the BMI scope in display unit 104 during testing result, for user's selection, option for example:
1, less than 18.5;
2、18.5～23.9；
3、24.0～27.9；
4, greater than 28.0.
The user imports analysis module 1033 can show the option that has the triglyceride scope in display unit 104 during input triglyceride testing result, for user's selection, option for example:
1、0.56-1.7mmol/L；
2、2.83-5.65mmol/L；
3, greater than 5.65mmol/L.
The user imports analysis module 1033 can show the option that has the serum creatinine scope in display unit 104 during input serum creatinine testing result, for user's selection, option for example:
1, less than 88.4 μ moI/L;
2、88.4-176.8μmoI/L；
3, greater than 176.8 μ moI/L.
Diabetes check and analysis device also comprises among another embodiment of the utility model as shown in Figure 5: Data Management Unit 106, be connected in described storage unit 104 and display unit 105, the blood sugar or the ketoboidies testing result that are used for retrieve stored, and by described display unit 105 demonstrations.
As shown in Figure 6, described Data Management Unit 106 further comprises: blood glucose level data retrieval module 1061, be used to receive the search condition of user's input, and according to described search condition to the storage blood sugar test result retrieve, obtain qualified blood sugar test result, and add up described these blood sugar test result's diagnostic result according to the blood sugar diagnostic result reference information that prestores; Ketoboidies data retrieval module 1062 is used to obtain the ketoboidies testing result of whole storages; Figure statistical module 1063 is used for generating bar chart or curve according to blood sugar test result who obtains or ketoboidies testing result.Described input block 105 also is connected in single 106 yuan of described data management, imports search condition for the user; Described display unit 104 also is used to show described result for retrieval.
Blood glucose level data retrieval module 1061 may command display units 105 show search condition for user's selection, and the user can select search condition, for example blood sugar test resulting class by input block 105:
1, whole blood sugar
2, blood sugar before the meal early
3, blood sugar after the meal early
4, ante prandium blood sugar
5, blood sugar after the lunch
6, blood sugar before the dinner
7, blood sugar after the dinner
8, the preceding blood sugar of sleeping
9, morning 2-3 point blood sugar
10, random blood sugar
Can also add another search condition, for example blood sugar test result's scope detection time:
1, all blood sugar
2, two all blood sugar
3, January blood sugar
4, the blood sugar bimester
5, March blood sugar
6, June blood sugar
7,1 year blood sugar
Blood glucose level data retrieval module 1061 receives the search condition that the user imports, and retrieves according to the blood sugar test result of described search condition to storage, according to described blood sugar test range of results that prestores and corresponding diagnostic result statistics result for retrieval thereof.Display unit 104 shows result for retrieval, and blood sugar type and time range according to user's selection will be inquired about demonstrate the blood sugar data of storing in the system, for example:
1, total (*) group blood sugar data
2, normally total (*) secondary data of glycemic control accounts for total (*) % of inquiry
3, well total (*) secondary data of glycemic control accounts for total (*) % of inquiry
4, total (*) secondary data of glycemic control difference accounts for total (*) % of inquiry
5, average blood sugar numerical value (*)
Figure statistical module 1063 generates bar chart or curve according to the blood sugar test result or the ketoboidies testing result of a period of time scope of obtaining, the chart area X-axis indicates the detection time of blood sugar test result or ketoboidies testing result, Y-axis indicates the unit (mmol/L of unit) of blood sugar test result or ketoboidies testing result, by with the blood sugar concentration numerical value of a period of time scope or ketoboidies concentration numerical value carries out cylindricality or curve shows, allow the user readily understand the blood sugar in the selected time range or the variation of ketoboidies.
As shown in Figure 7, diabetes check and analysis device of the present utility model also can comprise: usb interface unit 107, be connected in described storage unit 102, and be used for being connected with computing machine and upload or data download by the USB cable.
Diabetes check and analysis device of the present utility model also can comprise: alarm clock unit 108, the user can be provided with a plurality of reminder times, alarm clock unit 107 carries out auditory tone cues according to the reminder time that the user is provided with, and this function is intended to help to remind the user regularly to take medicine or beat insulin.
Diabetes check and analysis device of the present utility model also can comprise: radio reception unit 109, be used for FM radio, and listen to radio broadcast program.
Above-mentioned alarm clock unit 108 and radio reception unit 109 are connected in input block 105, and the user is provided with the frequency of reminder time and FM radio by input block 105.
The pick-up unit that the utility model provides adds the diagnoses and treatment inference system of specialty on the basis of existing fast detecting product, can carry out the analytical calculation and the state of an illness that the patient is current and the counter-measure of abnormal conditions to diabetes coherent detection result and inform the patient, the greatly current state of an illness of the understanding oneself of the fast simple science of the help patient of degree and promptly counter-measure, the harm that the deduction and exemption emergency condition is brought.
Above-described embodiment; purpose of the present invention, technical scheme and beneficial effect are further described; institute is understood that; the above only is the specific embodiment of the present invention; and be not intended to limit the scope of the invention; within the spirit and principles in the present invention all, any modification of being made, be equal to replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (8)
1. diabetes check and analysis device is characterized in that described device comprises:
Detecting unit is used to carry out blood sugar or ketoboidies and detects, and obtains testing result;
Input block is used for importing testing result for the user;
Storage unit, be connected in described detecting unit, be used for testing result classification and storage that described detecting unit is obtained, and the multiple diabetes dependent diagnostic reference information as a result that prestores, and the recommendation e-book of various diagnostic result correspondences, wherein every kind of described diagnostic result reference information comprises the diagnostic result of testing result and these testing result correspondences of different spans;
Analytic unit, be connected in described storage unit and input block, be used for after the testing result of described testing result of storage or reception user input, obtaining the recommendation e-book of diagnostic result and described diagnostic result correspondence according to the diagnostic result reference information of described testing result correspondence;
Display unit is connected in described analytic unit, is used to show the diagnostic result that described analytic unit obtains and recommends e-book.
2. diabetes check and analysis device as claimed in claim 1 is characterized in that described storage unit further comprises:
The blood sugar effects memory module is used for blood sugar test result queue time of will obtain and by different time period classification and storage;
Ketoboidies is memory module as a result, is used for the ketoboidies testing result mark time and the storage of will obtain;
The diagnostic data memory module, the multiple diabetes dependent diagnostic reference information as a result that is used to prestore, and the recommendation e-book of various diagnostic result correspondences.
3. diabetes check and analysis device as claimed in claim 2 is characterized in that described analytic unit further comprises:
The analysis of blood sugar module is used for according to the time of described blood sugar test result and mark, retrieving the recommendation e-book of diagnostic result and described diagnostic result correspondence in blood sugar diagnostic result reference information behind the described blood sugar test result of storage;
The ketoboidies analysis module is used for according to described ketoboidies testing result, retrieving the recommendation e-book of diagnostic result and described diagnostic result correspondence in ketoboidies diagnostic result reference information after the described ketoboidies testing result of storage;
The user imports analysis module, after the testing result of reception user input, according to the diagnostic result reference information of correspondence, obtains the recommendation e-book of diagnostic result and described diagnostic result correspondence.
4. diabetes check and analysis device as claimed in claim 2 is characterized in that described device also comprises:
Data Management Unit is connected in described storage unit and display unit, is used for the blood sugar or the ketoboidies testing result of retrieve stored, and shows by described display unit.
5. diabetes check and analysis device as claimed in claim 4 is characterized in that described Data Management Unit further comprises:
The blood glucose level data retrieval module, be used to receive the search condition of user's input, and according to described search condition to the storage blood sugar test result retrieve, obtain qualified blood sugar test result, and add up described these blood sugar test result's diagnostic result according to the blood sugar diagnostic result reference information that prestores;
The ketoboidies data retrieval module is used to obtain the ketoboidies testing result of whole storages;
The figure statistical module is used for generating bar chart or curve according to blood sugar test result who obtains or ketoboidies testing result.
6. diabetes check and analysis device as claimed in claim 1 is characterized in that described device also comprises: usb interface unit, be connected in described storage unit, and be used for being connected with computing machine and upload or data download by the USB cable.
7. diabetes check and analysis device as claimed in claim 1 is characterized in that described device also comprises: the alarm clock unit, be connected in described input block, and be used for carrying out auditory tone cues by the reminder time of input block setting according to the user.
8. diabetes check and analysis device as claimed in claim 1 is characterized in that described device also comprises: the radio reception unit, be connected in described input block, and be used for listening to radio broadcast program according to the frequency that the user selects by input block.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009201104483U CN201438187U (en) | 2009-07-28 | 2009-07-28 | Diabetes detection and analysis device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009201104483U CN201438187U (en) | 2009-07-28 | 2009-07-28 | Diabetes detection and analysis device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN201438187U true CN201438187U (en) | 2010-04-14 |
Family
ID=42400161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009201104483U Expired - Lifetime CN201438187U (en) | 2009-07-28 | 2009-07-28 | Diabetes detection and analysis device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN201438187U (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102364959A (en) * | 2011-10-31 | 2012-02-29 | 康佳集团股份有限公司 | Television system possessing health function and realization method thereof |
| CN102621327A (en) * | 2012-03-28 | 2012-08-01 | 中山市创源电子有限公司 | Intelligent blood glucose meter |
| CN102759627A (en) * | 2011-04-26 | 2012-10-31 | 爱科来株式会社 | Specimen measurement device and specimen measurement system |
| CN103210311A (en) * | 2010-12-28 | 2013-07-17 | 泰尔茂株式会社 | Blood glucose measuring device |
| CN103472010A (en) * | 2013-09-17 | 2013-12-25 | 苏州凯恩医药科技有限公司 | Diabetes detection device |
| CN103565521A (en) * | 2012-07-20 | 2014-02-12 | 数伦计算机技术（上海）有限公司 | Diabetes and cardiovascular and cerebrovascular disease monitoring and treatment system |
| CN104737022A (en) * | 2012-11-02 | 2015-06-24 | 霍夫曼-拉罗奇有限公司 | Systems and methods for multiple analyte analysis |
| WO2018191866A1 (en) * | 2017-04-18 | 2018-10-25 | 深圳华大基因研究院 | Type 2 diabetes marker, and use thereof |
-
2009
- 2009-07-28 CN CN2009201104483U patent/CN201438187U/en not_active Expired - Lifetime
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103210311A (en) * | 2010-12-28 | 2013-07-17 | 泰尔茂株式会社 | Blood glucose measuring device |
| CN102759627A (en) * | 2011-04-26 | 2012-10-31 | 爱科来株式会社 | Specimen measurement device and specimen measurement system |
| CN102759627B (en) * | 2011-04-26 | 2014-10-22 | 爱科来株式会社 | Specimen measurement device and specimen measurement system |
| US9055900B2 (en) | 2011-04-26 | 2015-06-16 | Arkray, Inc. | Specimen measurement device and specimen measurement system |
| CN102364959A (en) * | 2011-10-31 | 2012-02-29 | 康佳集团股份有限公司 | Television system possessing health function and realization method thereof |
| CN102621327B (en) * | 2012-03-28 | 2015-08-05 | 广东乐心医疗电子股份有限公司 | A kind of measuring method of intelligent blood glucose meter |
| CN102621327A (en) * | 2012-03-28 | 2012-08-01 | 中山市创源电子有限公司 | Intelligent blood glucose meter |
| CN103565521B (en) * | 2012-07-20 | 2016-06-22 | 数伦计算机技术（上海）有限公司 | A kind of diabetes, cardiovascular and cerebrovascular disease monitoring and treatment system |
| CN103565521A (en) * | 2012-07-20 | 2014-02-12 | 数伦计算机技术（上海）有限公司 | Diabetes and cardiovascular and cerebrovascular disease monitoring and treatment system |
| JP2016502656A (en) * | 2012-11-02 | 2016-01-28 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Systems and methods for multi-analyte analysis |
| JP2018128464A (en) * | 2012-11-02 | 2018-08-16 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | System and method for multiple analyte analysis |
| KR102046755B1 (en) | 2012-11-02 | 2019-11-19 | 에프. 호프만-라 로슈 아게 | Systems and methods for multiple analyte analysis |
| KR101802043B1 (en) * | 2012-11-02 | 2017-11-27 | 에프. 호프만-라 로슈 아게 | Systems and methods for multiple analyte analysis |
| KR20170131710A (en) * | 2012-11-02 | 2017-11-29 | 에프. 호프만-라 로슈 아게 | Systems and methods for multiple analyte analysis |
| US9921176B2 (en) | 2012-11-02 | 2018-03-20 | Roche Diabetes Care, Inc. | Systems and methods for multiple analyte analysis |
| US9958409B2 (en) | 2012-11-02 | 2018-05-01 | Roche Diabetes Care, Inc. | Systems and methods for multiple analyte analysis |
| CN104737022A (en) * | 2012-11-02 | 2015-06-24 | 霍夫曼-拉罗奇有限公司 | Systems and methods for multiple analyte analysis |
| US10466196B2 (en) | 2012-11-02 | 2019-11-05 | Roche Diabetes Care, Inc. | Systems and methods for multiple analyte analysis |
| KR20190084358A (en) * | 2012-11-02 | 2019-07-16 | 에프. 호프만-라 로슈 아게 | Systems and methods for multiple analyte analysis |
| KR102001330B1 (en) | 2012-11-02 | 2019-07-17 | 에프. 호프만-라 로슈 아게 | Systems and methods for multiple analyte analysis |
| CN103472010A (en) * | 2013-09-17 | 2013-12-25 | 苏州凯恩医药科技有限公司 | Diabetes detection device |
| CN110178035A (en) * | 2017-04-18 | 2019-08-27 | 深圳华大生命科学研究院 | Diabetes B marker and application thereof |
| WO2018191866A1 (en) * | 2017-04-18 | 2018-10-25 | 深圳华大基因研究院 | Type 2 diabetes marker, and use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN201438187U (en) | Diabetes detection and analysis device | |
| JP4891511B2 (en) | Method, system and computer program product for assessing diabetes blood glucose control from self-monitoring data | |
| JP6461885B2 (en) | Analyte testing method and device for diabetes management | |
| Parati et al. | European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring | |
| Ginsberg | Factors affecting blood glucose monitoring: sources of errors in measurement | |
| US20070282186A1 (en) | Blood glucose monitor with an integrated data management system | |
| Goetsch et al. | The effects of stress, mood, and coping on blood glucose in NIDDM: A prospective pilot evaluation | |
| Salkind et al. | Glycemic variability in nondiabetic morbidly obese persons: results of an observational study and review of the literature | |
| CN101785701B (en) | The device of information processing, method, equipment and reagent carrier | |
| CN1329511A (en) | A method and system for assisting user in medical self treatment | |
| CN110021437B (en) | Diabetes management method and system | |
| Knight et al. | The accuracy of wearable photoplethysmography sensors for telehealth monitoring: a scoping review | |
| Keshet et al. | Wearable and digital devices to monitor and treat metabolic diseases | |
| JP2003302406A (en) | Self blood sugar measurement system and self-blood sugar measurement unit | |
| Wilson et al. | Assessing glycaemic control: self-monitoring of blood glucose | |
| Litvinova et al. | Patent analysis of digital sensors for continuous glucose monitoring | |
| WO2021221591A1 (en) | System and method measuring glucose from urine | |
| CN117577262A (en) | Intelligent dynamic blood pressure management method and system based on large language model technology | |
| US20120259184A1 (en) | Blood glucose measurement device | |
| Foo et al. | Age-related factors that confound peripheral pulse timing characteristics in Caucasian children | |
| TWM560657U (en) | Interactive smart health management system | |
| Halter et al. | Indicators of function in the geriatric population | |
| Lin et al. | A Disposable Tear Glucose Biosensor—Part 5: Improvements in Reagents and Tear Sampling Component | |
| US20210196206A1 (en) | Systems and methods for sepsis risk evaluation | |
| Christiansen et al. | Home blood glucose monitoring: benefits for the patient and educator |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: BEIJING YICHENG BIOELECTRONIC TECHNOLOGY CO., LTD. Free format text: FORMER NAME: YICHENG BIOLOGICAL ELECTRONIC TECHNOLOGY CO., LTD., BEIJING |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 100016, No. 1, Jiuxianqiao East Road, Beijing, Chaoyang District, building No. 5, M2 Patentee after: Beijing Yi Cheng biological electronic technology limited company Address before: 100016, No. 1, Jiuxianqiao East Road, Beijing, Chaoyang District, building No. 5, M2 Patentee before: Beijing Yicheng Bioelectronic Technology Co., Ltd. |
|
| CX01 | Expiry of patent term |
Granted publication date: 20100414 |
|
| CX01 | Expiry of patent term |